import { seedPost, tldr, statStrip, comparisonTable, specList, tipCards, decisionTree, keyTakeaways, inlineCta, authorCard, tabbedFaq, sourceCitations, relatedGuides } from "../_seed-helper.mjs";

await seedPost("pharmacy-vending-machines", [
  tldr({
    heading: "What are pharmacy vending machines — and what can legally be dispensed in unattended settings?",
    paragraph:
      "Pharmacy vending machines (also called automated medication dispensing kiosks or unattended retail medication dispensers) are vending units capable of dispensing OTC (over-the-counter) medication and, in regulated jurisdictions, select prescription medication to consumers without a staffed pharmacist on site. The regulatory framework varies significantly by state and is the gating constraint for any deployment: OTC medication (acetaminophen, ibuprofen, naproxen, allergy + cold remedies, antacids, vitamins, electrolyte replenishment) is generally permissible via vending under FDA OTC monograph but limited by state pharmacy board (some states require age verification on Schedule V cough syrups, pseudoephedrine vending restricted under federal Methamphetamine Anti-Proliferation Act 2005), while prescription dispensing requires telepharmacy partnership (remote pharmacist consultation + verification via video link before dispense) and approval from state pharmacy board (Iowa, Idaho, Minnesota, North Dakota, others have approved framework; California, New York, Texas more restrictive). Major platforms: MedAvail Spotbox (Walmart partnership), Asteres ScriptCenter (Cardinal Health network), InstyMeds (urgent care + occupational health), Pharmabox (OTC focus at airports + transit). Best-fit placements: hospital staff break + family waiting areas, university health centers, airport + transit traveler placements (OTC focus), corporate occupational health at industrial plants, after-hours urgent care + ER overflow, rural underserved areas where pharmacy access is limited. Capital: $25-90K per machine depending on platform + prescription capability. Compliance: FDA labeling, state pharmacy board approval (prescription deployments), DEA registration where Schedule V dispensed, HIPAA where patient information involved, PCI-DSS payment, ADA accessibility. Operator capability: distinct from general vending — pharmacy-licensed operator or telepharmacy partnership required. Hosts evaluating pharmacy vending should engage state pharmacy board early, verify operator licensing, confirm placement traffic + payment-ready profile, plan for compliance audit, and limit initial deployment to OTC unless prescription framework is mature in jurisdiction.",
    bullets: [
      { emphasis: "Regulatory framework varies significantly by state — gating constraint:",
        text: "OTC permissible generally with state restrictions. Prescription requires telepharmacy partnership + state pharmacy board approval. Engage state board early; don't deploy prescription without approved framework." },
      { emphasis: "Best-fit placements: hospital, university health, airport, occupational health, after-hours urgent care:",
        text: "Underserved access + traveler/visitor demand + after-hours need drive placement economics. Most placements limited to OTC unless prescription framework mature." },
      { emphasis: "Capital $25-90K + pharmacy-licensed operator or telepharmacy partnership required:",
        text: "Distinct from general vending. Major platforms: MedAvail, Asteres ScriptCenter, InstyMeds, Pharmabox.", },
    ],
  }),
  statStrip({
    heading: "Pharmacy vending benchmarks",
    stats: [
      { number: "$25-90K", label: "capital per machine", sub: "depending on platform + prescription capability", accent: "blue" },
      { number: "State-by-state", label: "regulatory framework", sub: "engage pharmacy board early", accent: "orange" },
      { number: "OTC + Rx", label: "two distinct frameworks", sub: "Rx requires telepharmacy partnership", accent: "orange" },
      { number: "Hospital + university + travel", label: "best-fit placement profile", sub: "underserved access + after-hours demand", accent: "blue" },
    ],
  }),
  comparisonTable({
    heading: "OTC vending vs prescription dispensing — two distinct frameworks",
    sub: "OTC framework is permissible generally with state restrictions. Prescription framework requires telepharmacy partnership + state approval.",
    headers: ["Dimension", "OTC vending", "Prescription dispensing"],
    rows: [
      ["Regulatory primary", "FDA OTC monograph + state pharmacy board OTC rules", "State pharmacy board prescription + DEA where Schedule V + FDA"],
      ["Approval process", "State-specific; many states permit without specific approval", "State pharmacy board approval required; significant variation"],
      ["Operator licensing", "General vending operator with OTC sourcing capability", "Pharmacy-licensed operator OR telepharmacy partnership"],
      ["Telepharmacist required", "No (OTC self-selection)", "Yes — remote pharmacist verification via video link"],
      ["Dispensing scope", "Pain relief, allergy, cold, antacid, vitamins, electrolyte", "Antibiotics, chronic disease meds, post-discharge prescriptions, EpiPen + naloxone where authorized"],
      ["Patient identification", "Anonymous purchase", "Patient ID verification via ID scan + Rx number match"],
      ["HIPAA scope", "Limited (no patient information)", "Full HIPAA — patient data + Rx record"],
      ["Capital per machine", "$25-50K", "$50-90K"],
      ["Best-fit deployment", "Hospital visitor, airport, transit, hotel, university", "Hospital after-hours, rural underserved, post-discharge"],
    ],
  }),
  specList({
    heading: "Pharmacy vending machine specifications",
    items: [
      { label: "OTC dispensing scope", value: "Acetaminophen, ibuprofen, naproxen, aspirin (pain relief). Antihistamines + decongestants (allergy + cold; pseudoephedrine restricted under federal Methamphetamine Anti-Proliferation Act 2005). Antacids + heartburn (Pepcid AC, Tums, Prilosec OTC). Vitamins + electrolyte replenishment. Cough syrups including Schedule V where state-permitted with age verification. State pharmacy board may restrict specific SKUs." },
      { label: "Prescription dispensing — telepharmacy framework", value: "Remote pharmacist (licensed in dispensing state) consults with patient via video link before dispense. Verifies prescription, allergies, drug interactions, counseling. Approves dispense remotely. Approved frameworks: Iowa, Idaho, Minnesota, North Dakota, others — verify current status. Restrictive states: California, New York, Texas, others. MedAvail, Asteres ScriptCenter, InstyMeds platforms support telepharmacy integration." },
      { label: "MedAvail Spotbox platform", value: "Major prescription telepharmacy platform with Walmart partnership at retail placements. Patient picks up prescription via video link with remote pharmacist. Approved in select states. Integration with pharmacy benefit manager (PBM) for insurance verification. Capital $50-90K depending on configuration." },
      { label: "Asteres ScriptCenter platform", value: "Prescription dispensing kiosk with Cardinal Health network distribution. Pharmacy partner manages inventory + prescriptions; patient picks up at kiosk after Rx fill notification. Common at hospital + clinic placements. Capital $50-80K." },
      { label: "InstyMeds platform", value: "Urgent care + occupational health prescription dispensing. Doctor writes Rx in clinic; kiosk on site dispenses immediately. Common at after-hours urgent care, occupational health clinics at industrial plants, ER overflow. Capital $40-70K." },
      { label: "Pharmabox + Pharmabox-equivalent OTC platforms", value: "OTC-focused vending at airports, transit hubs, hotels, hospital visitor areas. Standard vending mechanism + OTC SKU sourcing + state pharmacy board compliance verification. Capital $25-50K. Major travel + hospitality placements." },
      { label: "State pharmacy board approval process", value: "Prescription deployments require state pharmacy board approval — application, demonstration of telepharmacy framework, patient counseling protocol, drug interaction protocol, controlled substance handling (where applicable). Process 3-12 months depending on state. OTC deployments generally not approval-required but state-specific verification recommended." },
      { label: "HIPAA + patient data compliance", value: "Prescription deployments involve patient data + Rx records + telepharmacist consultation. Full HIPAA compliance scope: patient data encryption, access logging, breach notification protocols, business associate agreements with pharmacy partner. Modern platform operators have HIPAA scope; new entrants may not. Verify HIPAA documentation." },
      { label: "DEA registration where Schedule V dispensed", value: "Schedule V (cough syrups, Lomotil, Lyrica low-dose) requires DEA registration + age verification + purchase log retention. Some states more restrictive than federal. Operator must hold DEA registration where applicable; verify at RFP." },
    ],
  }),
  tipCards({
    heading: "Six pharmacy vending deployment moves",
    sub: "Concrete moves to navigate pharmacy vending regulatory + operational complexity.",
    items: [
      { title: "Engage state pharmacy board early — before RFP", body: "State pharmacy board approval is gating for prescription dispensing. Engage pharmacy board 6-12 months ahead of planned deployment. Verify current OTC + prescription framework in jurisdiction. Some states approve quickly (Iowa, Idaho, Minnesota, North Dakota); others restrict (California, New York, Texas, others). Don't commit capital before regulatory framework verified." },
      { title: "Start with OTC scope if prescription framework is immature in your state", body: "OTC framework is more permissive nationally. Prescription requires telepharmacy partnership + state approval — significant variation. If state pharmacy board not yet approved prescription telepharmacy, deploy OTC first. Expand to prescription when state framework matures. Don't try to force prescription deployment in restrictive state." },
      { title: "Verify operator licensing + telepharmacy partnership before contract", body: "Pharmacy vending requires pharmacy-licensed operator (OTC + Rx) or telepharmacy partnership (Rx). Modern platforms (MedAvail, Asteres ScriptCenter, InstyMeds, Pharmabox) have established licensing + telepharmacy networks. Verify operator licensing documentation + DEA registration where Schedule V dispensed + state pharmacy board approval where Rx." },
      { title: "Build HIPAA + patient data compliance into operator scope (Rx deployments)", body: "Prescription deployments involve patient data + Rx records + telepharmacist consultation. Full HIPAA compliance: encryption, access logging, breach notification, business associate agreements with pharmacy partner. Modern platform operators have HIPAA scope; new entrants may not. Verify HIPAA documentation + recent audit before contract." },
      { title: "Match deployment placement to access-gap demand profile", body: "Pharmacy vending fills access gaps: hospital visitor areas (no nearby pharmacy + after-hours), university health centers (limited pharmacy hours), airport + transit (traveler + on-the-go demand), corporate occupational health (industrial plants without on-site pharmacist), after-hours urgent care + ER overflow, rural underserved (pharmacy desert). Don't deploy where staffed pharmacy already serves the need." },
      { title: "Plan for compliance audit + state pharmacy board inspection", body: "Pharmacy vending subject to compliance audit + state pharmacy board inspection. Modern operators manage audit response + inspection readiness as standard service; legacy operators may not have audit experience. Build audit support into operator contract. EH&S / compliance team should be looped in pre-deployment + at each renewal." },
    ],
  }),
  decisionTree({
    heading: "Should we deploy pharmacy vending at this placement?",
    question: "Does the placement fill a real access gap (after-hours, underserved area, traveler demand, on-site occupational health) AND is the state regulatory framework mature for the dispensing scope (OTC or Rx) AND can the operator demonstrate licensing + telepharmacy + HIPAA + audit experience?",
    yesBranch: {
      title: "Deploy pharmacy vending matched to access-gap profile.",
      description: "Engage state pharmacy board 6-12 months ahead of deployment. Start with OTC scope if Rx framework immature. Verify operator licensing + telepharmacy partnership + HIPAA documentation + DEA registration where applicable. Match deployment to access-gap demand (hospital visitor, university health, airport, occupational health, after-hours urgent care, rural underserved). Plan for compliance audit + state pharmacy board inspection.",
      finalTone: "go",
      finalLabel: "DEPLOY PHARMACY VENDING",
    },
    noBranch: {
      title: "Hold — address regulatory or access-gap prerequisites first.",
      description: "Either state regulatory framework immature for intended scope, OR placement doesn't fill genuine access gap (staffed pharmacy already serves), OR operator capability gap (licensing, telepharmacy, HIPAA, audit experience). Hold deployment, address prerequisites, revisit annually as regulatory framework matures or operator capability improves.",
      finalTone: "stop",
      finalLabel: "HOLD — FIX PREREQS",
    },
  }),
  keyTakeaways({
    heading: "Pharmacy vending key takeaways",
    takeaways: [
      "Regulatory framework varies significantly by state — gating constraint. OTC framework more permissive nationally; prescription requires telepharmacy partnership + state pharmacy board approval.",
      "Best-fit placements fill access gaps: hospital visitor + after-hours, university health, airport + transit, corporate occupational health, after-hours urgent care, rural underserved areas.",
      "Capital $25-90K per machine + pharmacy-licensed operator or telepharmacy partnership required. Major platforms: MedAvail Spotbox, Asteres ScriptCenter, InstyMeds, Pharmabox.",
      "Engage state pharmacy board 6-12 months ahead of deployment. Start with OTC if Rx framework immature in jurisdiction.",
      "HIPAA + patient data compliance required for Rx deployments. Verify operator HIPAA documentation + recent audit before contract.",
      "Plan for compliance audit + state pharmacy board inspection. Build audit support into operator contract.",
    ],
  }),
  inlineCta({
    text: "Want the pharmacy vending framework (regulatory + operator capability + placement fit + telepharmacy + compliance)?",
    buttonLabel: "Get the pharmacy vending framework",
    buttonHref: "/#get-machine",
  }),
  authorCard({
    bio: "Bobby Mac is equipped to advise on pharmacy vending deployment across hospital, university health, airport, transit, occupational health, after-hours urgent care, and rural underserved placements — including state pharmacy board engagement, OTC vs prescription scope selection, telepharmacy partnership evaluation (MedAvail Spotbox, Asteres ScriptCenter, InstyMeds, Pharmabox), HIPAA + patient data compliance scope, DEA registration where Schedule V dispensed, and operator licensing verification. The benchmarks reflect operator-side data on pharmacy vending economics and regulatory complexity.",
  }),
  tabbedFaq({
    faqs: [
      { question: "What is a pharmacy vending machine?", answer: "Vending unit capable of dispensing OTC medication and, in regulated jurisdictions, select prescription medication to consumers without a staffed pharmacist on site. OTC: pain relief, allergy, cold, antacid, vitamins. Prescription: requires telepharmacy partnership (remote pharmacist consultation via video link) + state pharmacy board approval. Major platforms: MedAvail Spotbox, Asteres ScriptCenter, InstyMeds, Pharmabox.", audience: "Operations" },
      { question: "Is pharmacy vending legal?", answer: "OTC framework is permissible generally under FDA OTC monograph with state restrictions (pseudoephedrine restricted, Schedule V cough syrups may require age verification). Prescription dispensing requires state pharmacy board approval and telepharmacy framework — Iowa, Idaho, Minnesota, North Dakota, others have approved. California, New York, Texas more restrictive. Engage state pharmacy board 6-12 months ahead of deployment.", audience: "Legal / Compliance" },
      { question: "What's the difference between OTC and prescription pharmacy vending?", answer: "OTC: self-selection, no telepharmacist, anonymous purchase, limited HIPAA scope, $25-50K capital, hospital visitor / airport / transit / hotel / university placements. Prescription: telepharmacist verification via video link, patient ID + Rx number match, full HIPAA scope, $50-90K capital, hospital after-hours / rural underserved / post-discharge placements.", audience: "Operations / Legal" },
      { question: "Where do pharmacy vending machines fit best?", answer: "Access-gap placements: hospital visitor + after-hours, university health centers (limited pharmacy hours), airport + transit (traveler demand), corporate occupational health (industrial plants without on-site pharmacist), after-hours urgent care + ER overflow, rural underserved (pharmacy desert). Don't deploy where staffed pharmacy already serves the need; access gap is the value proposition.", audience: "Property Managers / Health Systems" },
      { question: "What operator capability is required?", answer: "OTC: general vending operator with OTC sourcing capability + state pharmacy board compliance verification. Prescription: pharmacy-licensed operator OR telepharmacy partnership with established platform (MedAvail, Asteres, InstyMeds). DEA registration where Schedule V dispensed. HIPAA documentation + recent audit for Rx deployments. Verify operator licensing + reference deployment in comparable jurisdiction.", audience: "Procurement" },
      { question: "What about HIPAA compliance?", answer: "OTC deployments have limited HIPAA scope (no patient information). Prescription deployments involve patient data + Rx records + telepharmacist consultation — full HIPAA scope: patient data encryption, access logging, breach notification protocols, business associate agreements with pharmacy partner. Modern platform operators have HIPAA scope; new entrants may not. Verify HIPAA documentation + recent audit.", audience: "Compliance / IT Security" },
      { question: "What about pseudoephedrine and Schedule V medications?", answer: "Pseudoephedrine restricted under federal Methamphetamine Anti-Proliferation Act 2005 — purchase logging + ID required, sales limits per individual. Many states prohibit pseudoephedrine via vending. Schedule V (cough syrups, Lomotil, Lyrica low-dose) requires DEA registration + age verification + purchase log retention. Verify operator DEA registration where Schedule V dispensed.", audience: "Compliance / Legal" },
      { question: "How long does deployment take?", answer: "OTC deployment 60-120 days (operator selection + state verification + installation + go-live). Prescription deployment 12-18 months (state pharmacy board approval 3-12 months + telepharmacy partnership setup + HIPAA + installation + telepharmacist scheduling). Engage state pharmacy board early; regulatory timeline is the long-pole item for Rx deployments.", audience: "Operations / Implementation" },
    ],
  }),
  sourceCitations({
    sources: [
      { label: "FDA — OTC drug monograph and unattended retail standards", url: "https://www.fda.gov/drugs/over-counter-otc-nonprescription-drugs", note: "Federal OTC drug regulation underlying pharmacy vending OTC scope and labeling" },
      { label: "DEA — Methamphetamine Anti-Proliferation Act + Schedule V framework", url: "https://www.deadiversion.usdoj.gov/", note: "Federal controlled substance framework underlying pharmacy vending Schedule V + pseudoephedrine restrictions" },
      { label: "MedAvail Spotbox — telepharmacy prescription dispensing platform", url: "https://www.medavail.com/", note: "Major telepharmacy prescription dispensing platform with Walmart partnership and state-approved frameworks" },
      { label: "HHS HIPAA — patient data privacy and security standards", url: "https://www.hhs.gov/hipaa/", note: "Federal HIPAA framework underlying pharmacy vending prescription deployment patient data compliance" },
      { label: "National Association of Boards of Pharmacy (NABP) — state pharmacy board directory", url: "https://nabp.pharmacy/", note: "State pharmacy board directory for engaging state regulatory framework on pharmacy vending deployments" },
    ],
  }),
  relatedGuides({
    heading: "Related specialty vending guides",
    items: [
      { eyebrow: "Sister guide", title: "Specialty vending machine overview", description: "Eight specialty categories, placement fit, capital, regulatory framework, and operator capability.", href: "/specialty-vending-machines/specialty-vending-overview" },
      { eyebrow: "Operations", title: "Electronics vending machines", description: "Placement fit, SKU mix, secure dispensing, warranty pass-through, and operator capability.", href: "/specialty-vending-machines/electronics-vending-machines" },
      { eyebrow: "Hub", title: "All specialty vending machine guides", description: "Categories, placement fit, regulatory framework, and operator capability for specialty vending.", href: "/specialty-vending-machines" },
    ],
  }),
]);
process.exit(0);
